Adoptive Cellular Therapy and Radiation Therapy After Surgery in Treating Patients With Esophageal Cancer

Inclusion Criteria: * cytologically or histologically confirmed esophageal carcinoma * Tumor extension beyond muscularis propria and/or nodal involvement without evidence of M1 disease * Prior en bloc resection, with curative intent, of all known tumor * No metastatic disease * Age: \> 18 * Karnofsky performance status ≥ 70 * At least 3 weeks since prior surgery * Normal functions of heart, lung, liver, kidney and bone marrow * Blood exams qualified for chemotherapy, which included hemoglobulin ≥9 g/dl, neutrophil ≥1.5×109/L and platelet (PLT) ≥100×109/L, creatinine ≤1.5 UNL * All patients must be evaluated by a radiation oncologist prior to enrollment to ensure patient is appropriate for radiotherapy * Informed consent signed Exclusion Criteria: * Patients with metastatic disease. * Patients who are pregnant or nursing. * Patients with poor bone marrow, liver and kidney functions, which would make radiation therapy intolerable * Patients with contraindication for irradiation: complete obstruction of esophagus, deep esophageal ulcer, fistula to mediastinum, or haematemesis